Global Statistics

All countries
Updated on June 23, 2022 1:32 am
All countries
Updated on June 23, 2022 1:32 am
All countries
Updated on June 23, 2022 1:32 am

Global Statistics

All countries
Updated on June 23, 2022 1:32 am
All countries
Updated on June 23, 2022 1:32 am
All countries
Updated on June 23, 2022 1:32 am
- Advertisment -

Is Covid Vaccine Safe For Elderly

Is There Risk Of Allergic Reaction From Covid

Are COVID-19 vaccines safe and effective for seniors?

According to the CDC, anyone who has a known severe allergy to any of the vaccine ingredients should not receive that vaccine.

The CDC says people with allergies to certain foods, insects, latex and other common allergens can safely receive the COVID-19 vaccine. Those with a history of severe allergic reaction to injectables or other vaccines should discuss the vaccination with their doctor, who can evaluate and assess their risk.

How Do We Know a COVID-19 Vaccine Will Be Safe and Effective?

Johnson & Johnson Vaccine

In April 2021, the Johnson & Johnson vaccine was paused while the FDA and the Centers for Disease Control and Prevention investigated a small number of cases of rare blood clots in people who had received that vaccine. Nearly all reports of this problem have been in adult women younger than age 50. After careful review, the FDA and CDC recommended that administration of the J&J COVID-19 vaccine could safely resume. Johns Hopkins Medicine followed these recommendations, temporarily pausing and then resuming use of the J&J vaccine.

Can People With Underlying Health Conditions Such As Multiple Sclerosis Receive The Vaccine Right Now

Spivak: Yes, they can receive the vaccine. The CDC has a list of certain medical conditions and what specific recommendations are for vaccination. Many underlying conditions are risk factors for severe COVID-19 and worse outcomes. Therefore, people with underlying health conditions are encouraged to get the vaccine when it becomes available to them.

Don’t Miss: How To Make Covid Test Less Painful

Developing Vaccines For A Key Demographic

People age 65 and over suffer the most severe cases of COVID-19 and have the highest associated mortality rate. If the goal is to have COVID-19 vaccines ready for public use by early 2021, the only ones that have a chance are those that are currently in clinical trials. It is likely that most of these did not undergo preclinical optimization for an elderly population, meaning these first-generation COVID-19 vaccines may perform poorly in the people that need them most.

For the COVID-19 pandemic, it is too late to go back and build these considerations into preclinical testing. However, it is imperative that researchers still in the preclinical phase incorporate head-to-head testing of their vaccine candidates in young versus aged animals and develop strategies to optimize them in the latter. This will help the world prepare for the next outbreak of a dangerous coronavirus.

For that matter, a focus on the elderly should be incorporated into other vaccine development programs, including those to treat cancers, which have the highest incidence in older people.

There are viable strategies to improve the effectiveness of vaccines in older people, including changes in formulations, doses and routes of administration. However, it takes substantial time and appropriate animal models to conduct this research. It is possible that the elderly may need fundamentally different vaccination regimens than younger people.

Do The Vaccines Protect Against The Variants

50 elderly persons take COVID vaccine at Enmore Polyclinic ...

The optimism that came with the approval of COVID-19 vaccines in late 2020 was tempered by the emergence of several coronavirus variants that had mutated to be more contagious, deadlier, and potentially able to evade the vaccines.

But the data so far suggest that currently available vaccines work well against the variants.

Chen says that those who are vaccinated and later infected with one of the concerning variants are still unlikely to be hospitalized. Though there is little real-world data on how the vaccines work against the B.1.351 variant a particularly concerning one first detected in South Africa one small clinical trial for the AstraZeneca vaccine was halted after it showed only 22% efficacy against the variant. Notably, none of the vaccinated people, who were generally low-risk for severe COVID-19 to begin with, were hospitalized or died.

The World Health Organization says that the vaccines are likely to provide at least some protection against each of the variants because they prompt a broad immune response beyond just targeting the spike protein that is the focus of the vaccines.

Pfizer and Moderna have begun testing third booster shots of the vaccines to see if the extra dose could provide further protection against the variants. They are also developing variant-specific vaccines targeting the B.1.351 variant.

Edwards would not be surprised if it turns out that people need to continue to get COVID-19 booster shots as additional variants emerge.

You May Like: Can Colleges Require Covid Vaccines

What Happens After I Get The Vaccine Can I Stop Wearing My Mask And Social Distancing

None of the vaccines are 100% effective. An efficacy rate of 95%, for instance, means that some people who get vaccinated may still get COVID-19.

If you are one of the many who do develop immunity, it usually takes 2-4 weeks after you complete the vaccine series to do so. You could get infected during this time, endangering your health. You might also still be able to spread the disease, both during this 2-4 week window as well as after you develop full immunity, endangering others.

Once most people are protected, restrictions may ease up. In the meantime, continue to wear your mask, practice social distancing, avoid crowds and wash your hands often.

Do I Still Have To Wear A Mask And Continue Covid

The CDC continues to monitor the spread of COVID-19 and makes recommendations for wearing face masks, both for those who are;fully vaccinated;as well as those who are not fully vaccinated.

The CDC also recommends that masks and physical distancing are required when going to the doctors office, hospitals or long-term care facilities, including all Johns Hopkins hospitals, care centers and offices.

Johns Hopkins Medicines current mask safety guidelines have not changed, and we still require all individuals to wear masks inside all of our facilities.

Recommended Reading: How Many Times Can You Get Covid 19

What About The Delta Variant Do The Vaccines Protect Against Delta

Like all viruses, the virus causing COVID-19 mutates frequently. These variants may differ in their ability to infect, trigger an immune response and induce illness.

The delta variant is one of the more recent strains of the virus causing COVID-19. It is even more contagious than earlier strains, causing a new surge in cases especially among the young.

Whether our current COVID-19 vaccines can sufficiently protect against the delta variant has been a concern. However, the current data are reassuring. We strongly advise you to get one of the available COVID-19 vaccines.

Should I Be Worried About Vaccine Safety

Covid-19 vaccine ‘effective in elderly’

Over the past months, millions of people in the U.S. have been safely vaccinated. The FDA has fully approved the Pfizer-BioNTech COVID-19 vaccine, and may fully approve other coronavirus vaccines in the future. The FDA and CDC continue to carefully monitor each of the authorized COVID-19 vaccines for safety concerns.

These organizations are being thorough and transparent. One example is that in April 2021 the CDC and FDA paused administration of the J&J vaccine so they could review data on a few reported cases of serious blood clots following vaccination with that vaccine. After this review, the FDA and CDC determined that the benefits of the J&J vaccine outweigh the risk of this very rare side effect, and authorized vaccination with the J&J shot to resume.

Similarly, after observing rare occurrences of myocarditis following the second injection of the Pfizer and Moderna COVID-19 vaccines, the CDC released information for the public.

They will continue to communicate with the public about their findings and any possible safety issues with this or any other COVID-19 vaccine. Any potential safety risks of COVID-19 vaccines must be weighed against the known serious risk of harm due to the COVID-19 infection and the benefits of protection that the vaccines offer.

You May Like: Is A Sore Throat A Covid Symptom

Can Educators And Older Adults Get The Vaccine Through U Of U Health

Spivak: Aside from employees, U of U Health is not currently providing the vaccine to the public. The Utah Department of Health is vaccinating groups in the public through local county health departments. You should contact your local county health department for vaccination distribution information.

Should People Be Concerned About Experiencing Adverse Reactions To The Vaccine

Spivak: Eleven in a million people have experienced severe allergic reactions to the vaccine, which is extremely rare. These are allergic reactions like swelling, itching, and difficulty breathing. Allergic reactions to the COVID-19 vaccines are very uncommon and tend to occur in people who had previous allergic reactions to other medications or vaccines. Overall, severe side effects are rare, and the likelihood of experiencing an adverse reaction to the vaccine is far less common than the rate of getting COVID-19.

Don’t Miss: How To Get A Free Covid Test

What Are The Covid Vaccine Side Effects

Some people notice side effects of the COVID-19 vaccine, such as pain or swelling where they got the vaccine. You may also get fever, muscle aches, chills, fatigue, headaches or a combination of these symptoms.

COVID-19 vaccine side effects may last about a day or two, and do not signify illness. These are signs that your immune system is responding and preparing to fight the coronavirus if you catch it. If symptoms persist, you should call your doctor.

Would A Vaccine Booster Shot Help People With A Heart Condition


Many vaccines require booster shots, sometimes every year, so it is possible that we will require a new dose of the current or new COVID-19 vaccines. As of now, booster shots have been authorized for emergency use by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention only for individuals with weakened immune systems who may have had a reduced response to the initial treatment. It is possible that in the future, this authorization will be expanded for everyone or for people with other medical conditions, such as heart disease.

Don’t Miss: How Do They Test For Covid Antibodies

Why Older Adults Are Excluded From Trials

In a research letter published in September 2020 in JAMA Internal Medicine, the authors detailed their review of 847 COVID-19 treatment and vaccine trials to evaluate their risk for the exclusion of older adultssomething the authors note there is a history of in clinical trials.

The review found that older adults are likely to be excluded from more than 50% of COVID-19 clinical trials and nearly 100% of vaccine trials.

Such exclusion will limit the ability to evaluate the efficacy, dosage, and adverse effects of the intended treatments, the authors wrote. We acknowledge that some exclusions for severe or uncontrolled comorbidities will be essential to protect the health and safety of older adults. However, caution must be taken to avoid excluding otherwise eligible participants for reasons that are not well-justified.

Hashmi says that the exclusion of older adults in drug development and research is not unusuallargely because of the same anxiety many people are feeling now about safety, adverse side effects, and efficacy.

Pfizer reported that its vaccine is 94% effective in people 65 and older. Moderna has reported that its vaccine is more than 95% effective, and a separate FDA analysis showed 86% efficacy in adults 65 and older.

From a research perspective, there are also ethical considerations when involving a population with potential memory concerns because they have to give their consent to participate.;

Cnbc Health & Science

During an earnings call Tuesday, Mikael Dolsten, Pfizer’s chief scientific officer, said it makes sense to start with those most susceptible, such as older adults and those with chronic diseases that make them more vulnerable to severe illness and hospitalization, such as cardiovascular disease or asthma.

The Centers for Disease Control and Prevention makes recommendations to states on who should get the shots first.

“We cannot predict” what the CDC will do, Dolsten said.

Dolsten’s comment comes after the company reported that sales of its Covid-19 vaccine boosted its first-quarter financial results.

The company now expects full-year sales of $26 billion from the vaccine, up from its previous forecast of about $15 billion. It expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

“Based on what we’ve seen, we believe that a durable demand for our Covid-19 vaccine, similar to that of the flu vaccines, is a likely outcome,” Pfizer CEO Albert Bourla told investors on the earnings call.

Should Americans require booster shots, the U.S. government would likely need to make arrangements with the drugmakers to supply additional doses and make plans for vaccine distribution.

Also Check: How Many People Have Died From Covid

Does Race And Immigration Status Factor Into Who Gets The Vaccine First

The national phased approach for distribution doesnt specifically call out race and/or immigration status among the subpopulations at risk; however, some states have spoken up about the issue. In New York, for example, Governor Andrew Cuomo has said his state will not tolerate inequity in COVID vaccine distribution. On,;he wrote, Black and brown communities that were first on the list of who died cannot be last on the list of who receives the vaccine.

Williams agrees with viewing vaccine distribution from a lens of health equity. We cannot leave the have-nots behind as the surge peaks, he says. We know 37% of volunteers in the Moderna vaccine trial came from communities of color. Those same vulnerable communities must be prioritized to receive the vaccine when its released.

We also know nearly 45,000 undocumented immigrants are working as nursing assistants and nearly 30,000 are working as home health aides, according to research conducted by the New American Economy, a bipartisan research and advocacy organization. Vaccination for these frontline healthcare workers is also essential in helping reduce the risk of infection among our nations seniors.

Latest On Coronavirus From New Scientist

Is the COVID vaccine safe for seniors?

Vaccine evidence: A UK study has found that protection from the Pfizer/BioNTech and Oxford/AstraZeneca vaccines wanes over time. Both vaccines provide good protection against symptomatic infections by the delta coronavirus variant, but are around 15 per cent less effective against delta than against the alpha variant. The findings also imply that vaccinated people who do get infected might be just as infectious as unvaccinated people.

The ventilation problem: Maximising airflow in public spaces is crucial to cut covid-19 transmission, but questions remain about what technology to use and how effective it needs to be.;

Taranaki Street in Wellington, New Zealand, during the first day of a national lockdown.

You May Like: How Many Types Of Covid Vaccines Are There

Have There Been Any Covid

Issues concerning the Johnson & Johnson COVID-19 vaccine and a rare incidence of myocarditis after the Pfizer and Moderna COVID-19 vaccines, as noted above have been reported.

Trials for the vaccines have had fully independent safety monitoring boards, and safety data are continuously reviewed by the FDA and expert panels. The number of serious problems in test participants was very low, and there was little difference between those who received the actual vaccine and those who received a placebo. Millions of people have received the vaccines since their authorization, and careful safety monitoring of all three COVID-19 vaccines continues.

Some People Might Be Worried About Getting The Vaccine Due To The Unknown Long

Supiano: Wed like to have more long-term data, but the data we do have about COVID-19 is so chilling that the benefit of getting the vaccine outweighs the risk of getting COVID-19. If you are an older adult and are unfortunate enough to get COVID-19, your risk of death is extraordinarily high. Whats even more compelling is that people who have recovered from the virus are experiencing devastating long-term side effects.

Don’t Miss: Does Pine Sol Kill Covid

Vaccines Are Safe And Effective At Preventing Severe Illness From Covid

The U.S. Food and Drug Administration issued full approval of the Pfizer-BioNTech COVID-19 vaccine for those ages 16 and older. This full approval from the FDA further indicates how safe and effective the vaccines are at preventing severe illness from COVID-19.

There continues to be an Emergency Use Authorization from the FDA for the Pfizer-BioNTech vaccine for those ages 12-15, and an EUA for the Moderna and Janssen/Johnson & Johnson vaccines for those ages 18 and older.

The key difference between full approval and an EUA is the length of time spent studying those who have received the vaccine, including a longer review period of data associated with any adverse events. Anyone who has remained hesitant about the vaccines should use this full approval as motivation to get the two-dose Pfizer vaccine as soon as possible.

The two-dose Moderna vaccine and single-shot Janssen/Johnson & Johnson vaccines are also incredibly effective in protecting against severe illness from COVID-19.

All eligible South Carolinians should get fully vaccinated as soon as possible. Being fully vaccinated and wearing masks are by far the best ways to protect yourself and others from COVID-19, including the hypertransmissable delta variant.

Getting fully vaccinated and wearing masks are the best ways to protect our children and the teachers who care for them, and these are also the best tools we have for keeping our students physically in the classroom, where we know they thrive.

Injection Site Pain Headache Fatigue Are Most Common


Here’s some good news: A key finding from clinical trial data and from the first few months of vaccine rollout is that older adults have fewer side effects from a COVID-19 vaccine compared to younger populations.

“If there’s a little bit of a silver lining to this cloud, it’s that we who have gray hair are less likely to experience these reactions, says William Schaffner, an infectious disease expert and professor of preventive medicine and health policy at Vanderbilt University.

The likely reason has to do with a declining immune response that comes with age, experts say. However, a lack of reaction or a diminished one doesn’t mean the body isn’t building protection against COVID-19. Large-scale clinical trials and real-world data show that the three federally authorized vaccines from Moderna, Pfizer-BioNTech and Johnson & Johnson are highly effective at preventing severe illness from a coronavirus infection across all age groups. So these are very strong vaccines, Schaffner says.

Don’t Miss: How To Sleep If You Have Covid

- Advertisment -

Hot Topics

- Advertisment -

Related Articles